LYEL Archived Articles
Lyell Immunopharma (LYEL): Overcoming Obstacles and Pivoting to Next-Gen CAR T-Cell Therapies
Published on November 02, 2024
Lyell Immunopharma, Inc. (NASDAQ:LYEL): Advancing Novel Cell Therapies for Solid Tumors
Published on September 24, 2024